CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells

ICAM-1 signaling in endothelial cells

(2014) Charlotte Lawson et al.   Pharmacological Reports

Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3

(2011) W. Yang et al.   HUMAN REPRODUCTION

Prostaglandin E2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells

(2010) Shun-Fa Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cell Adhesion Molecules: Role and Clinical Significance in Cancer

(2009) Nektaria Makrilia et al.   CANCER INVESTIGATION

Prognostic relevance of CCN3 in Ewing sarcoma

(2009) Bernard Perbal et al.   HUMAN PATHOLOGY

CCN3 – A key regulator of the hematopoietic compartment

(2008) L. McCallum et al.   BLOOD REVIEWS

Prognostic Value of CCN3 in Osteosarcoma

(2008) B. Perbal et al.   CLINICAL CANCER RESEARCH

Inhibitors Targeting the LFA-1/ICAM-1 Cell-Adhesion Interaction: Design and Mechanism of Action

(2008) Tahl Zimmerman et al.   CURRENT PHARMACEUTICAL DESIGN

Functions and mechanisms of action of CCN matricellular proteins

(2008) Chih-Chiun Chen et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Screening for Prostate Cancer: An Update

(2007) Richard J. Bryant et al.   EUROPEAN UROLOGY